Bayer Sees Increased Demand Across All Consumer Health Categories In Q1

Bayer Consumer Health reported sales up in all categories and regions in the first quarter of 2022, with demand particularly high for dietary supplements and cough & cold products.

Bayer cross
• Source: Bayer

A recovery in cough and cold product sales, plus strong demand for dietary supplements helped Bayer Consumer Health post big gains in the first quarter of 2022. Bayer CEO Werner Baumann told the German firm’s Q1 earnings call that the Consumer Health business had “continued its broad-based growth trajectory” over the three months.

Consumer Health sales advanced by 20.8% to €1.51bn ($1.60bn) in the period as Bayer benefited from a favorable comparison with...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Europe

More from Geography